Table 3.
Between group comparison.
| Baseline | Month 24 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Control (n = 24) | ADT (n = 36) | p-valuea | Control (n = 23) | ADT (n = 24) | p-value | |||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | |||
| Health assessment | ||||||||||
| Body mass index (BMI) | 23.15 | 2.83 | 23.75 | 3.08 | 0.448 | 22.90 | 2.87 | 24.37 | 2.97 | 0.020* |
| Waist to hip ratio | 0.95 | 0.06 | 0.96 | 0.06 | 0.604 | 0.93 | 0.07 | 0.98 | 0.06 | 0.018* |
| Body fat (%) | 28.32 | 3.60 | 29.89 | 5.49 | 0.186 | 28.12 | 3.17 | 32.44 | 3.65 | 0.012* |
| Laboratory evaluation | ||||||||||
| Total cholesterol | 5.17 | 0.85 | 4.96 | 0.86 | 0.353 | 4.81 | 0.87 | 4.46 | 0.85 | 0.791 |
| Triglyceride | 1.35 | 0.63 | 1.58 | 0.89 | 0.286 | 1.18 | 0.43 | 1.56 | 0.83 | 0.673 |
| High density lipoprotein (HDL) | 1.54 | 0.39 | 1.53 | 0.41 | 0.948 | 1.60 | 0.43 | 1.26 | 0.32 | 0.012* |
| Low density lipoprotein (LDL) | 3.02 | 0.80 | 2.75 | 0.75 | 0.183 | 2.67 | 0.81 | 2.49 | 0.74 | 0.779 |
| Fasting blood glucose level | 5.86 | 1.02 | 6.39 | 1.99 | 0.237 | 6.00 | 0.97 | 6.74 | 2.34 | 0.989 |
| Glycosylated hemoglobin level (HbA1C) | 6.14 | 0.74 | 6.15 | 0.78 | 0.966 | 6.13 | 0.69 | 6.50 | 1.71 | 0.491 |
| Framingham risk | 39.79% | 19.86% | 41.74% | 20.94% | 0.720 | 37.67% | 19.93% | 47.24% | 22.86% | 0.018* |
| Vascular assessment | ||||||||||
| Systolic blood pressure | 143.40 | 18.48 | 161.32 | 123.33 | 0.484 | 138.41 | 13.25 | 144.44 | 24.61 | 0.161 |
| Diastolic blood pressure | 84.13 | 10.59 | 74.61 | 9.55 | 0.001* | 80.33 | 8.85 | 73.58 | 11.10 | 0.148 |
| Ankle-brachial index (ABI) | 1.13 | 0.10 | 1.03 | 0.15 | 0.008 | 1.12 | 0.12 | 1.01 | 0.14 | 0.602 |
| Pulse wave velocity (PWV) | 17.79 | 2.70 | 17.66 | 4.30 | 0.889 | 18.21 | 3.75 | 20.52 | 6.34 | 0.024* |